WuXi Biologics named in 2026 Dow Jones Best-in-Class World Index and Emerging Markets Index

Clearway Health recognised with 2026 Great Place To Work Certification for fourth consecutive year

Servier's Emi-Le receives US FDA breakthrough therapy designation for adenoid cystic carcinoma

Insilico Medicine enters strategic collaboration agreement with Ribo

Bavarian Nordic secures USD97m US vaccine contract expansion and raises 2026 outlook

Cellular Intelligence and Novo Nordisk enter agreement to advance clinical-stage Parkinson's cell therapy

Ranok Therapeutics reports positive Phase 1a clinical results for KRAS G12D inhibitor RNK08954

Avid Bioservices names new chief commercial officer

AnaCardio reports Phase 1b/2a data showing cardiac function gains with AC01

Inhibrx reports positive interim Phase 2 data for INBRX-106 in first-line head and neck cancer

Anixa Biosciences reports extended survival signals in Phase 1 ovarian cancer CAR-T trial

Oncopeptides plans EMA filing to broaden Pepaxti indication

GSK partners with SBP Group to accelerate China launch of bepirovirsen

Harbour BioMed's HBM7004 receives US FDA IND clearance for Phase I trial

Wenda Pharma's oral BET inhibitor NHWD-870 HCI receives Breakthrough Therapy Designation in China in advanced NUT carcinoma